SCHEMBL23070996

SCHEMBL23070996

CN1CCN(CCn2cc(-c3cc(Oc4ccc(N)cc4F)ccn3)cn2)CC1

nearest known ligand 0.55

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 4/20 0.55
▸ CSF1R P07333 12/20 0.44
▸ PDGFRA P16234 5/20 0.44
▸ FLT3 P36888 4/20 0.44
▸ MET P08581 4/20 0.44
▸ PDGFRB P09619 3/20 0.44
▸ FGFR1 P11362 2/20 0.38
▸ FGFR2 P21802 1/20 0.38
▸ FGFR3 P22607 1/20 0.38
▸ KDR P35968 2/20 0.37
▸ EGFR P00533 1/20 0.37
▸ PIM1 P11309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29736783 1.00 AXL (0.55) AXLCSF1RPDGFRAFLT3MET
SCHEMBL23081321 0.85 AXL (0.60) AXLCSF1RPDGFRAFLT3MET
SCHEMBL2418677 0.83 CSF1R (0.55) AXLCSF1RPDGFRAFLT3MET
SCHEMBL29736560 0.83 CSF1R (0.55) AXLCSF1RPDGFRAFLT3MET
SCHEMBL29814290 0.80 AXL (0.54) AXLCSF1RPDGFRAFLT3MET
SCHEMBL23071318 0.80 AXL (0.54) AXLCSF1RPDGFRAFLT3MET
SCHEMBL2539404 0.79 MET (0.47) AXLMETKDREGFR
SCHEMBL828141 0.77 AXL (0.62) AXLCSF1RPDGFRAFLT3MET
SCHEMBL828378 0.77 AXL (0.59) AXLCSF1RPDGFRAFLT3MET
SCHEMBL23071332 0.76 AXL (0.51) AXLCSF1RPDGFRAFLT3MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021043217-A1 COMPOUND HAVING AXL AND C-MET KINASE INHIBITORY ACTIVITY, PREPARATION THEREOF AND APPLICATION THEREOF 中国科学院上海药物研究所 2021-03-11 — — WO disclosed
WO-2021043217-A1 COMPOUND HAVING AXL AND C-MET KINASE INHIBITORY ACTIVITY, PREPARATION THEREOF AND APPLICATION THEREOF 中国科学院上海药物研究所 2021-03-11 — — WO disclosed
Send feedback